Gevo, Inc. (GEVO) Form 10-K Annual Reports
Gevo, Inc. (GEVO) is a publicly traded company on the Nasdaq, categorized under SIC 2860 (Industrial Organic Chemicals). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GEVO
CIK: 1392380
Exchange: Nasdaq
SIC 2860: Industrial Organic Chemicals
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDerek Bradfield
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0001628280-26-060768 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0001628280-26-060767 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0001628280-26-060764 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001972481-26-000277 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001972481-26-000276 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001972481-26-000275 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001972481-26-000274 | View SEC Doc Filr Page |
| 3 | 2026-08-26 | 2026-08-20 | FORM 3 | 0001628280-26-059127 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-20 | FORM 8-K | 0001104659-26-101084 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-21 | FORM 4 | 0001628280-26-058727 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-21 | FORM 4 | 0001628280-26-058725 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | FORM 4 | 0001628280-26-058724 | View SEC Doc Filr Page |
| 3 | 2026-08-24 | 2026-08-20 | FORM 3 | 0001628280-26-058723 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-13 | FORM 4 | 0001628280-26-056839 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0001628280-26-054929 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0001628280-26-054927 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0001628280-26-054926 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0001628280-26-054925 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000472 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054462 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001972481-26-000253 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001972481-26-000252 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001972481-26-000251 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001972481-26-000249 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001972481-26-000248 | View SEC Doc Filr Page |